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Natural compounds are known to modify NO content in tissues; however, the biological activity of 
polyphenol-rich food often does not correspond to the effects of individual polyphenols on NO synthase 
activity. The aim of this study was to see how natural compounds luteolin, indole-3-carbinol, and lycopene 
modify NO production in rat tissues and change the expression of the iNOS gene and protein. Indole-3-
carbinol produced multiple effects on the NO level; it signifi cantly decreased NO concentration in blood, 
lungs, and skeletal muscles and increased it in the liver. Indole-3-carbinol enhanced lipopolyssaccharide 
(LPS)-induced NO production in all rat organs. It decreased iNOS gene expression in the brain cortex 
of animals that did not receive LPS and up-regulated it in the LPS-treated animals. Lycopene increased 
the iNOS gene transcription rate in the brain cortex of LPS-treated animals. Luteolin did not modify NO 
production in any organ of LPS-untreated rats, nor did it affect gene expression in the liver. In the brain it 
slightly decreased iNOS gene expression. Luteolin decreased NO production in the blood of LPS-treated 
animals and the number of iNOS-positive cells in these animals. Our results suggest that changes in tissue 
NO levels caused by natural compounds cannot be predicted from their effect on NOS expression or 
activity obtained in model systems. This stresses the importance of direct measurements of NO and NOS 
expression in animal tissues.
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Natural biologically active compounds of plant 
origin such as flavonoids are widely used as 
dietary supplements with detoxicating effects. The 
detoxicating effect of many plant-derived compounds 
is based on their antioxidant, anti-mutagenic, and 
anti-carcinogenic effects (1, 2). These substances are 
also known to infl uence the enzymatic production of 
nitric oxide (NO) and its stability. (3). This underlines 
the signifi cance of the uptake of fl avonoid and other 
natural compound for the defence of cardiovascular, 
immune, and nervous systems against toxins. 
However, the biological activity of polyphenol-rich 
food does not correspond to the effects of individual 
compounds on NO synthase activity. For example, 
red wine is known as a vasodilator (4) and is rich 
in quercetin. Purifi ed quercetin inhibits inducible 
nitric oxide synthase (iNOS) gene expression (3, 5), 
destabilises endothelial NOS (eNOS) mRNA (6), 
and even inhibits NOS enzymatic activity (7). Yet it 
produces vasorelaxing effects (8) despite the fact that 
nitric oxide is not detected in rat aorta after quercetin 
administration (9).
We believe that the effects of natural compounds 
on NO production in animal organs are particularly 
important for evaluation of their biological activity. 
Unfortunately, such data are scarce (9, 10). The aim 
of our study was to see if and to what extent natural 
compounds of plant origin modify NO production 
in rat tissues using electron spin resonance (ESR) 
spectroscopy of Fe - diethylthiocarbamate – nitric 
oxide [Fe(DETC)
2
-NO] complexes. We also assayed 
iNOS gene expression using the real-time reverse 
transcriptase polymerase chain reaction (RT-PCR) 
and iNOS protein synthesis using histochemical 
methods. 
MATERIALS AND METHODS
For the study we selected three compounds of 
different chemical structure: luteolin, a polyphenolic 
flavonol, indole-3-carbinol, a simple phenolic 
compound, and lycopene, the carotene derivative. 
Their chemical structures are given in Figure 1. 
Literature data indicate possible impact of all the three 
substances on NOS expression and/or NO production 
(11-19).
Luteolin, 3’,4’,5’,7-tetrahydroxyflavone is 
abundant in celery root, rutabaga, red pepper, spinach, 
and flowering plants such as Ajuga decumbens, 
Taraxacum officinale (dandelion), and Medicago 
sativa (alfalfa). Luteolin is known as a dietary 
compound with antioxidant activity (11).
Indole-3-carbinol (3-indolmethanol) is found in 
mustard plants (Brassica sp.) including cabbage, 
broccoli, and Brussels sprouts. The compound has 
widely been studied for cancer treatment (12).
Lycopene, ψ, ψ-carotene is found in ripe red 
vegetables such as tomato. It is an antioxidant and 
detoxicating agent (13).
Chemicals
Indole-3-carbinol, lycopene, luteolin, and 
acetyl ester of caffeic acid were purchased from 
Dayang Chemical Co., LTD (Hangzhou, China). 
Lipopolysaccharide, diethylthiocarbamate, ferrous 
sulphate, sodium citrate, TRI Reagent®, and all other 
chemicals were from Sigma-Aldrich Chemie GmbH 
(Taufkirchen, Germany).
Experiment design and compound administration
Male Wistar rats, weighing (215.00±5.63) g at the 
beginning of the experiment, were obtained from the 
Laboratory of Experimental Animals, Riga Stradins 
University, Riga, Latvia. All experimental procedures 
Figure 1 Chemical structure of natural compounds used in the study
Luteolin Lycopene
Indole – 3 – carbinol Ester of caffeic acid
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followed the guidelines set out in the Directive 
86/609/EEC (20) and were approved by the Animal 
Ethics Committee of the Food and Veterinary Service 
(Riga, Latvia).
The animals were kept in a stable environment at 
(22±0.5) °C with a 12-hour light/dark cycle and fed 
standard laboratory diet. Tables 1 and 2 give details 
about animal groups, their number, and administered 
compounds.
ESR experiments included animal groups 1 to 10 
(Table 1). Natural compounds were administered per 
os to model their natural mode of consumption. Three 
and a half hours later the spin trap was injected. Thirty 
minutes afterwards the rats were decapitated under 
slight ether narcosis. Groups 6 to 10 received 10 mg 
kg-1 of lipopolyssaccharide (LPS) by intraperitoneal 
injection to simulate an iNOS produced outburst of 
NO synthesis. Groups 11 to 26 (Table 2) were used 
for real-time RT-PCR and immunohistochemistry. 
Natural compounds and LPS were administered four 
hours before decapitation under slight ether narcosis. 
Liver or brain cortex tissues were taken for RNA 
extraction or immunohistochemical analysis. We used 
at least fi ve animals per group for ESR experiments 
and at least three animals for real-time RT-PCR and 
immunohistochemistry. The number of animals in the 
control and LPS groups was greater to ensure reliable 
reference.
Administration of spin trap agents 
To determine NO production level we used ESR 
spectroscopy of paramagnetic Fe - diethylthiocarbamate 
– nitric oxide complex [(Fe(DETC)
2
-NO)] (21-26). 
Rats received 400 mg kg-1 b. m. of nitric oxide 
scavenger diethylthiocarbamate via intraperitoneal 
injection and ferrous citrate subcutaneously (ferrous 
sulphate 40 mg kg-1 + sodium citrate 200 mg kg-1) 30 
minutes before sacrifi ce. Diethylthiocarbamate binds 
ferrous ion and the resulting complex traps nitric 
oxide, converting it to paramagnetic Fe(DETC)
2
-NO 
complex that is detected by ESR spectroscopy.
Sacrifi ce, organ dissection and sample preparation 
for ESR
The rats  were decapitated under sl ight 
ether anaesthesia after compound and spin trap 
administration. Samples of brain cortex, cerebellum, 
myocardium tissue, liver, kidney, testes, skeletal 
muscles, lungs and blood were compacted into a glass 
tube 30 mm in length with inner diameter of 4 mm 
and immediately frozen in liquid nitrogen. Before 
Table 1  Effects of luteolin, lycopene, and indole-3-carbinol on NO production (ng g-1 tissue in 30 min ) in different organs and 
tissues of intact rats and under lipopolysaccharide (LPS)-treated and LPS-untreated rats
Group
NO / ng g-1
Cortex Cerebellum Liver Heart Kidney Testes Blood Lungs Spleen Muscle
1. Control, n=24 51.6±4.7 20.0±2.8 35.6±4.3 0.3±0.2 5.8±1.5 13.5±3.5 53.6±5.2 69.9±8.0 35.7±3.2 20.5±2.0
2.
Indole-3-carbinol
(50 mg kg-1), n=9
50.7±7.0 17.9±2.0 56.3±9.2* 2.1±1.2 6.6±1.4 9.0±1.9 32.3±3.3* 49.1±4.4* 35.1±2.5 6.5±2.2*
3.
Luteolin
(50 mg kg-1), n=5
58.3±16.1 - 25.1±6.7 0 4.4±2.0 - 43.9±13.0 75±6.9 - -
4.
Lycopene
(50 mg kg-1), n=10
58.8±9.7 - 41.6±11.4 1.3±0.8 8.2±2.1 - 46.6±5.2 56.5±8.1 - -
5.
Caffeic acid ester
(50 mg kg-1), n=6
37.8±8.4 21.2±4.5 53.8±12.3 2.0±1.3 0.0 9.6±3.7 35.9±8.6 43.1±8.4 33.7±7.0 12.2±1.0*
6.
LPS
(10 mg kg-1), n=28
163.2±12.2 115.6±12.1 1344.6±124.0 253.0±20.7 323.8±24.4 56.9±9.6 401.1±30.4 793.3±68.4 796.0±50.6 105.6±16.3
7.
Indole-3-carbinol
(50 mg kg-1)+LPS, n=12
241.4±18.4# 211.9±17.7# 1903.0±175.5# 381.7±29.4# 464.1±33.8# 115.8±19.7# 649.2±56.0# 1302.8±154.8# 1254.1±129.5# 186.9±17.5#
8.
Luteolin
(50 mg kg-1)+LPS, n=4
167.3±28.5 - 1318.5±298.0 179.8±43.6 262.5±48.5 - 253.3±43.6# 846.8±135.7 - -
9.
Lycopene
(50 mg kg-1)+LPS, n=6
165.0±9.6 - 1328.8±156.5 238.2±19.6 332.0±27.4 - 461.0±53.4 901.7±54.2 - -
10.
Caffeic acid ester
(50 mg kg-1)+LPS, n=6
143.8±15.3 135.7±18.8 1685.7±190.5 254.8±28.3 352.8±38.5 63.0±8.5 452.5±61.0 841.7±85.4 880.2±98.1 148.3±21.1#
* P<0.05 vs. control group, # P<0.05 vs. LPS-treated group.
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ESR measurements
ESR spectra were recorded in liquid nitrogen 
using an ESR spectrometer “Radiopan” SE/X2544 
(Radiopan, Poznan, Poland) under the following 
conditions: operation at X-band, 25 mW microwave 
power, 100 kHz modulation frequency, 5 G modulation 
amplitude, receiver gain 0.5x104, and time constant 
1 s. The spectra were recorded for 4 minutes. NO 
content in the samples was determined from the height 
of the third component of the NO signal at g=2.031.
NO mass fraction (ng g-1 of tissue) was calculated 
on the basis of calibration curves, as described 
previously (22-26). Briefl y, different quantities of 
NaNO
2
 [in fi nal concentrations of (10, 20, 30, 40, 
60, and 100) µmol L-1] were mixed with DETC 




O (3.3 mmol L-1). 






 (2 mol L-1) was added to the 
mixture. The EPR spectra were measured as described 
above.
RNA extraction and cDNA preparation
Total RNA was isolated from the liver and 
brain cortex using TRI Reagent® (Sigma Aldrich, 
Taufkirchen, Germany). DNA contaminations were 
removed with DNA-free kit (Ambion, Austin, TX, 
USA). The resulting RNA quantity and purity were 
determined by spectrophotometry and the integrity of 
RNA molecules was monitored by gel electrophoresis. 
Only specimens with well-pronounced rRNA 
bands were taken for reactions. RNA (2 μg) was 
reverse-transcribed using a random hexamer primer 
(RevertAid™ First Strand cDNA Synthesis Kit, 
Fermentas, Vilnius, Lithuania) to obtain cDNA.
Real-time RT-PCR
mRNA expression in the brain cortex, liver iNOS, 
and reference gene were determined using the SYBR® 
Green PCR Master Mix (Applied Biosystems, Foster 
City, CA, USA) according to instructions provided 
by the manufacturer. Amplifi cation and detection of 
specifi c products were performed on a StepOne™ 
Real-Time PCR System (Applied Biosystems, Foster 
City, CA, USA) using the following temperature-time 
profi le: the fi rst 10-minute cycle at 95 °C followed 
by 40 4-second cycles at 95 °C and then by a 1-
minute cycle at 60 °C. To check the specifi city of 
amplifi cation products, we used the dissociation curve 
mode (alternating one 4-second cycle at 95°C, with 
one 1-minute at 60 °C, and then again one 4-second 
at 95°C). To evaluate the suitability of candidates for 
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recording the ESR spectra, the tubes were placed in 
quartz fi nger Dewar fl asks ER 167 FDS-Q (Bruker, 
Karlsruhe, Germany) fi lled with liquid nitrogen.
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reference genes, we applied the GeNorm program 
(27; http://medgen.ugent.be/genorm/). Primers 
were designed using Primer3 software. The primers 
were supplied by Metabion international AG, 
Germany. The results were analysed using the 2–∆∆CT 
method. Primer sequences for iNOS gene were 5’-
GCTACACTTCCAACGCAACA-3’ for forward 
and 5’- CATGGTGAACACGTTCTTGG-3’ for 
reverse primer, and the expected size of the product 
was 116 bp. Cyclophilin A (sequence NM_017101, 
primers 5’-AGCACTGGGGAGAAAGGATT-3’ 
and 5’-AGATGCCAGGACCTGTATGC-3’, 175 
bp), porphobilinogen deaminase (NM_013168, 
5’-ATCTTGCACCCAGAGGAATG-3’ ,  5’-
CATGCAACACACCCACTAGG-3’, 106 bp), RNA-
polymerase II (5’-GCCAGAGTCTCCCATGTGTT-
3’ and 5’-GTCGGTGGGACTCTGTTTGT-3’, 135 
bp), glyceraldehyde-3-phosphate dehydrogenase 
(NM_017008, 5’-TCGTCTCATAGACAAGATGG-
3 ’ ,  1 4 1 b p ) ,  a n d  b e t a - a c t i n  ( 5 ’ -
AGCCATGTACGTAGCCATCC-3’ and 5’-
ACCCTCATAGATGGGCACAG-3’, 115bp) were 
chosen as reference genes.
Histological and immunohistochemical analysis
Paraffi n-embedded tissue was cut in 4-micron-
thick sections and stained with haematoxylin and 
eosin for morphological analysis. Infiltration of 
infl ammatory cells in brain tissue was assessed in the 
subcortical perivascular, subcortical parenchymal, 
and intracortical perivascular regions (magnifi cation 
400x). Perivascular infiltrates were defined as 
infl ammatory cells, which are located not further than 
three cell layers from blood vessels. Infl ammatory 
cells further than three layers from a blood vessel wall 
were defi ned as parenchymal infi ltrates. Infi ltration of 
infl ammatory cells was assessed according to a four-
score scale: 0 – no infi ltration; 1 – light infi ltration; 2 
– medium infi ltration; 3 – marked infi ltration; 4 – very 
marked infi ltration (more than 25 % of the total fi eld 
of vision).
The morphology of the liver tissue was evaluated 
through histological activity index (HAI) according 
to infi ltration of infl ammatory cells (0 to 4 scores), 
necrosis of hepatocytes around the central vein (0 
to 6 scores), necrosis of hepatocytes and apoptosis 
in peripheral lobules (0 to 4 scores), infl ammatory 
changes of portal tracts (0 to 4 scores) (28).
Tissue sections were stained for visualisation 
of iNOS-positive cells using an immunochemical 
method described elsewhere (29). Briefl y, antigen was 
retrieved by treatment in citrate buffer, pH=6.0, in a 
microwave oven at 300 W for 20 min. Endogenous 





10 min. Nonspecifi c primary antibody binding was 
blocked by serum-free protein block for 10 min. 
Rabbit polyclonal active iNOS antibody Abcam 
Inc. (Cambridge, MA, USA) was applied in a 1:200 
dilution and incubated in a humidifi ed chamber at 
room temperature for 1 h. Primary antibody binding 
was detected using specifi c peroxidase conjugated 
polyclonal goat anti-rabbit IgG (1:100 for 30 min) 
and subsequently peroxidase conjugated polyclonal 
rabbit anti-goat IgG (1:100 for 30 min). For staining 
we used diaminobenzidine for 7 min. Each staining 
run included a negative control without primary 
antibody.
iNOS-positive cells were counted in twenty high-
powered fi elds at magnifi cation of 400x. All cell counts 
were expressed as cells per square millimetre.
The same observer performed at least three 
replicate measurements of iNOS-positive cells in 10 
randomly selected slides. Intraobserver coeffi cient 
of variation was 4 % and intraobserver correlation 
coeffi cient was 0.94.
Statistical analysis
Results are expressed as means ± SD. The 
significance of differences in NO concentration 
and iNOS expression between groups was 
evaluated according to Student’s unpaired t-test. 
The Mann-Whitney U test was used to quantify 
immunohistochemical experiments.
RESULTS
Effects of natural compounds on NO production 
in LPS-treated and untreated rats
Table 1 and Figure 2 summarise our fi ndings on 
NO production in rat organs and tissues under the 
infl uence of selected natural compounds.
To determine baseline NO levels, LPS-untreated 
rats were injected with DETC and ferrous citrate. 
EPR spectra of tissue samples measured 30 min later 
had a typical Cu-DETC shape with a superposed 
Fe(DETC)
2
-NO peak, as published elsewhere (22, 
25). 
NO levels were the highest in the cortex, cerebellum, 
liver, lungs, muscles, spleen, and blood and an order 
of magnitude lower in the heart, kidney, and testes. 
Indole-3-carbinol caused a signifi cant decrease in NO 
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concentration in the blood, lungs, and skeletal muscles 
and  an increase in the liver. Luteolin and lycopene 
did not infl uence NO production in LPS-untreated 
animals.
Intraperitoneal injection of LPS caused a drastic 
increase in NO levels in all tissues studied (Table 1, 
Figure 2). The highest accumulation was detected in 
the liver, followed by  heart, blood, and kidney (50 
to 100 times the control values). However, the effects 
of LPS were less pronounced in the brain tissues and 
the testes, where NO increased only 4 to 6 times. 
Lycopene did not significantly modify the LPS-
induced NO production, while luteolin decreased it 
in blood only. In contrast, indole-3-carbinol enhanced 
the LPS-induced  NO production in all organs (Table 
1, Figure 2). To test if this was specifi c for indole-3-
carbinol, we tested another phenolic compound, acetyl 
ester of caffeic acid for reference, and it did not have 
this effect (Table 1).
Effects of natural compounds on iNOS gene mRNA 
expression in LPS-treated and untreated rats
We saw no effect of the three compounds on iNOS 
expression in the liver  (Figure 2). However, indole-3-
carbinol inhibited its expression in the brain cortex by 
reducing its transcription rate up to (16.61±11.82) % 
from the baseline level. 
As expected from increased NO production 
(3,442.82±761.24), LPS strongly increased iNOS gene 
expression in the liver. However, the effect was not 
comparable between animals.
Indole-3-carbinol enhanced iNOS mRNA 
expression (7,715.01±1,877.35) % compared to 
control, but this increase was not statistically 
signifi cant.
In the brain cortex, LPS triggered a marked increase 
in iNOS gene mRNA copies [(1,089.92±528.33) % 
compared to LPS-untreated animals]. This correlated 
with increase in NO production. Indole-3-carbinol 
and lycopene enhanced this effect further still to 
(2,564.00±153.39) % and (2,900.00±1015.52) %, 
respectively.
Effects of natural compounds on iNOS protein 
expression in LPS-treated and untreated rats
A few iNOS-positive cells were observed in 
the liver and brain cortex of the control group. 
Microphotographs are presented in Figure 3.
In the liver of LPS-treated animals we observed 
increased infl ammatory cell infi ltration in portal tracts, 
venous congestion, and hepatocyte apoptosis. In 
addition, LPS signifi cantly increased iNOS expression 
in Kupfer cells (nuclear immunolocalisation) and 
hepatocytes compared to control (cytoplasmic 
Figure 2  Effects of lycopene, luteolin and indole-3-carbinol on iNOS gene expression (white columns), number of iNOS-positive 
cells (dashed columns), and NO production (grey columns) in the liver (A-B) and brain cortex (C-D). Results are 
presented as percentage vs. average of the control.
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localisation, (62.0±4) cells per mm2 vs. (9.00±3.512) 
cells per mm2 (P=0.0002; Figure 3). Still in the liver, 
luteolin down-regulated LPS-induced increase in 
infl ammatory cell count by (44.67±6.64) cells per 
mm2. The same tendency was observed for lycopene 
and indole-3-carbinol, but these differences are not 
statistically signifi cant.
Luteolin and indole-3-carbinol combined with 
LPS signifi cantly decreased fatty degeneration and 
infl ammatory cell infi ltration and inhibited apoptotic 
changes in hepatocytes.
In the brain cortex, LPS induced major 
histopathological changes manifested as perivascular 
and pericellular oedema, apoptosis, and infl ammatory 
cell infi ltration (Figure 4). In addition, LPS triggered 
a signifi cant increase in cells containing iNOS in the 
brain cortex [(28.67±3.71) cells per mm2]. Indole-3-
carbinol and luteolin reduced these changes in the 
brain cortex.
Modifi cation of NF-kB expression by luteolin
Inhibitory action of fl avonoids on iNOS expression 
is often achieved by suppression of NF-kB expression 
(12). It was interesting to determine to which extent 
LPS and luteolin modify the expression of this 
transcription factor in the lung, myocardium, and brain 
Figure 3  iNOS expression in the liver tissue in control and LPS-treated group assessed by immunohistochemical methods. 
A – control; B – LPS; C – LPS+luteolin. Arrows indicate positively stained cells, magnifi cation 200x.
Figure 4  Photomicrographs of rat brain cortex tissue stained with haematoxylin-eosin (A-B) and immunohistochemically with 
iNOS antibody (C-F). Magnifi cation is 100x in A-C and 400x in D-F. A, C -control, B, D - LPS at dose 10 mg kg-1; E 
– lycopene treatment (50 mg kg-1); F – simultaneous administration of lycopene and LPS. Arrows indicate infl ammatory 
cell infi ltration in brain cortex (B) and iNOS-positive cells (D-F).
A
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cortex. Figure 5 shows staining of the lung tissue. 
In the lungs, LPS provoked NF-kB expression in 
bronchial epithelial cells and infl ammation cells. LPS 
combined with luteolin decreased positive cell count 
from (364±54) cells per mm2 to (203±24) cells per 
mm2 (P=0.02) in the airway subepithelium. However, 
luteolin did not modify the LPS-induced expression of 
the transcription factor in the airway epithelium and 
alveoli walls. In the heart and brain cortex, luteolin 
could not induce any signifi cant changes in the number 
of NF-kB-positive cells.
DISCUSSION
Luteolin is known as a weak inhibitor of iNOS 
expression, but it is not capable of inhibiting enzyme 
activity (11, 14-17). Some authors fi nd that luteolin 
stimulates eNOS gene expression (18). Our fi ndings 
show no direct evidence of inhibition of iNOS 
expression. An indirect sign could be lower blood 
NO level in LPS-treated animals. Our results are 
consistent with fi ndings of lower iNOS expression 
in glial cells (15). A possible mechanism of iNOS 
inhibition by luteolin could be via inhibition of NF-
kB. It was demonstrated that luteolin signifi cantly 
blocks LPS-induced IkB phosphorylation/degradation, 
NF-kB transcriptional activity, and intercellular 
adhesion molecule-1 (ICAM-1) gene expression in 
rat IEC-18 cells (30). In our study, luteolin inhibited 
LPS-induced NF-kB expression in the lung tissue. 
However, it appears that luteolin does not signifi cantly 
modify NO production at the organism level. Judging 
by suppression of the transcription factor expression 
detectable only in the airways subepithelium, iNOS 
inhibition by luteolin is restricted to a few organs. 
In the liver, luteolin lowered iNOS expression both 
in Kupffer cells and macrophages. Kupffer cells 
are immunocompetent cells; they produce various 
cytokines, chemokines, and adhesion molecules, 
and this process is regulated by NF-kB. The known 
antioxidant properties of luteolin might also contribute 
to its anti-infl ammatory action.
Indole-3-carbinol is a weak iNOS inhibitor (19). 
The substance interferes with several signalling 
pathways (2). From our experiments, there are 
indications that the substance may decrease iNOS 
gene expression in the brain cortex of LPS-untreated 
animals. The lowering of NO concentration in blood, 
lungs, and skeletal muscles may also indirectly 
indicate some iNOS-inhibiting activity of the 
compound. Amazingly though, the compound even 
enhanced LPS-induced gene transcription in the 
brain cortex, and the same tendency was observed 
for the liver. Indole-3-carbinol also increased NO 
production in the liver of  animals which did not 
receive LPS. In LPS-treated animals it increased NO 
production in all studied organs. Whether indole-
3-carbinol will increase or decrease NO production 
depends on the tissue and physiological features of the 
animal. NO decreasing activity of indole-3-carbinol 
can be explained by its capability to reduce NF-kB 
DNA binding activity (2 and references therein, 12). 
Moreover, the substance was shown to inhibit Akt 
kinase activity, which lowers NF-kB expression (2 
and references therein, 12). In our study, indole-3-
carbinol lowered LPS-induced iNOS expression in 
Kupffer cells and hepatocytes and lowered iNOS 
expression in the brain cortex of LPS-untreated rats. It 
also lowered infl ammatory cell infi ltration in the brain 
cortex tissue. These observations are compatible with 
the above mechanisms. The ability of the compound 
to increase NO production in some organs, especially 
in LPS-treated animals, might also be attributed to 
the antioxidant activity of indole-3-carbinol (19). 
Scavenging of reactive oxygen species prevents 
Figure 5  NF-kBp65 expression in the lung tissue. A - control, B - LPS (10 mg kg-1, i.p., 4 h), C - LPS+luteolin (50 mg kg-1, p.o., 
4h). Immunohistochemical staining with NF-kBp65 rabbit polyclonal antibody (1:100). Arrow indicates positively 
stained cells, magnifi cation 200x.
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their interaction with NO, which may increase its 
bioavailability. This effect is associated with several 
natural compounds, including cocoa polyphenols 
(31) and resveratrol (32). A similar effect is produced 
by kaempferol, also known as an inhibitor of iNOS 
expression; it enhances LPS-induced NO production 
in blood (33).
Our results suggest that the effects of natural 
compounds on NO metabolism are organ-specifi c. 
Indole-3-carbinol enhanced NO production in the 
liver of LPS-untreated rats, but reduced it in their 
blood, lungs, and skeletal muscles. It inhibited iNOS 
gene expression in the brain cortex, but not in the 
liver. Similarly, lycopene enhanced LPS-triggered 
iNOS gene transcription in the brain cortex, but not 
in the liver.
Moreover, the correlation between iNOS gene or 
protein expression and NO level in a given tissue is 
not always linear. It seems that iNOS expression does 
not limit NO production in the LPS model used in our 
study. Discrepancies can arise for several reasons, 
including the antioxidant activity of a compound. 
In this case scavenging of reactive oxygen species 
makes NO more available (31, 32). The ability of 
a compound to increase NOS expression or activity 
in vitro can be attenuated at the organism level. 
Excessive NO seems to inhibit NOS activity, but the 
drop in NOS activity does not necessarily affect NO 
level in tissues (34). Note that it is NO that mostly 
affects physiological processes in tissues. In our 
opinion, the effects, and therefore recommendations 
on the use of a natural compound should be based on 
direct tissue NO measurements after the compound’s 
administration. Our morphological analyses indicate 
that luteolin and indole-3-carbinol protect the liver 
and brain tissue against LPS-induced degenerative 
changes and confi rm their anti-degenerative and anti-
infl ammatory potential.
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Sažetak
DJELOVANJE LIKOPENA, INDOL-3-KARBINOLA I LUTEOLINA NA STVARANJE DUŠIKOVA 
MONOKSIDA I EKSPRESIJU iNOS-GENA U ŠTAKORA OVISI O ORGANU
Zna se da prirodni spojevi utječu na sadržaj NO u pojedinome tkivu. Ipak, biološka aktivnost hrane bogate 
polifenolima često ne odgovara djelovanju pojedinih polifenola na aktivnost NO-sintaze. Cilj je ovoga 
ispitivanja bio utvrditi kako prirodni spojevi luteolin, indol-3-karbinol i likopen utječu na stvaranje NO u 
tkivu štakora te kako utječu na ekspresiju gena i razine inducibilne sintaze dušikova monoksida (iNOS). 
Indol-3-karbinol višestruko je utjecao na razinu NO; značajno je snizio njegovu koncentraciju u krvi, 
plućima i skeletnim mišićima, ali ju je povisio u jetri. Također je povećao njegovo stvaranje u svim organima 
štakora koji su primili lipopolisaharide (LPS). U kori mozga životinja koje nisu primile LPS doveo je do 
smanjenja ekspresije iNOS-gena, a u onih koje su primile LPS do njegova povećanja. Likopen je doveo do 
ubrzane transkripcije iNOS-gena u kori mozga životinja koje su primile LPS, ali nije utjecao na stvaranje 
NO u životinja koje nisu primile LPS, odnosno na ekspresiju gena u jetri. U mozgu životinja koje nisu 
primile LPS doveo je do laganoga smanjenja ekspresije iNOS-gena. Luteolin je povećao stvaranje NO u 
krvi životinja koje su primile LPS te njihov broj iNOS-pozitivnih stanica. Naši rezultati upućuju na to da 
se promjene razina NO uzrokovane prirodnim spojevima ne daju predvidjeti na temelju ekspresije gena 
iNOS odnosno aktivnosti toga enzima dobivene na modelu. Stoga je veoma važno izravno mjeriti razine 
NO i ekspresiju NO-sintaze u tkivu životinja.
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